Bavarian Nordic gets FDA approval for chikungunya vaccine
Bavarian Nordic (OTCPK:BVNRY) has received FDA approval for its vaccine Vimkunya for the prevention of chikungunya. The virus-like particle, or VLP, vaccine is approved for people aged 12 and older.
MercoPress1d
Chikungunya: 43 deaths and 11,467 cases confirmed in Paraguay
According to the Hospital Central del Instituto de Previsión Social (IPS), about 30% of its staff is on bed rest after being diagnosed with chikungunya. “We estimate that 30 % of our staff is ...
Abc Color4h
Generalidades de la Estadística
a) Estadística descriptiva o deductiva: se basa en la recolección de datos y su clasificación, elaboración de tablas y gráficos que resumen esos datos; además, como la determinación de ...
MarketWatch1d
Deere & Co.
XCMG Construction Machinery Co. Ltd.-0.51% ¥92.99B Hitachi Construction Machinery Co. Ltd.-0.18% ¥812.54B Doosan Bobcat Inc. 3.01% ₩4.8T HD Hyundai Infracore Co. Ltd. 14.16% ₩1.79T HD ...